Lipomics venture wins new backing
By Dale Kasler, Bee Staff Writer
Sacramento Bee
(Published Jan. 3, 2004)
A Sacramento wing of a prominent Silicon Valley venture capital firm
has made its first deal in the Sacramento area, leading to an investment
in a biotech company.
DFJ Frontier, an affiliate of Redwood City's highflying Draper
Fisher Jurvetson, said Friday it led a $2.1 million investment in
Lipomics Technologies Inc.
of West Sacramento. Lipomics said it is talking to other potential
investors in hopes of bringing the deal to $2.5 million.
Lipomics uses the study of the fatty acids known as lipids to predict
diseases. Its spokeswoman, Jan Kingsbury, said the fresh investment
dollars will be used to beef up its science staff and move to a
bigger headquarters on West Sacramento's Industrial Boulevard.
The Lipomics deal represents DFJ Frontier's fourth investment
but its first in Sacramento.
Lipomics has been doing great things, said Scott Lenet, managing
director of DFJ, adding that it is the kind of company that gave
DFJ the confidence to open an office in Sacramento.
DFJ, which also has an office in Santa Barbara, was bankrolled
with $20 million from the California Public Employees' Retirement
System. The fund opened its office in Sacramento in late 2002 and
made its first three investments in Chico, Santa Cruz and San Diego.
The investment represents Lipomics' third round of financing and
its first from a venture capital firm. Its first two rounds were
financed by so-called angel investors, some of whom participated
in this latest round as well. DFJ's share was $500,000.
|